Pharma D Intertech Co., Ltd. is a Company Limited, established on 18 Feb 2021 and registered in Bangkok, Thailand. The Company’s principal business is manufacture of parfumes, cosmetics and toilet preparations. Pharma D Intertech Co., Ltd. has been operating for 5 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Pharma D Intertech Co., Ltd.
- Registration number
- 0105564029860
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 18 Feb 2021
- Registered capital (THB)
- THB 1,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of parfumes, cosmetics and toilet preparations
Contact DetailsRegistered contact information
- Registered address
- 17/9, Hathai Rat, Bang Chan, Khlong Sam Wa, Bangkok 10510
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
ShareholderShareholding of Pharma D Intertech Co., Ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Pharma D Intertech Co., Ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Pharma D Intertech Co., Ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Pharma D Intertech Co., Ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Pharma D Intertech Co., Ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Pharma D Intertech Co., Ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
